2013
DOI: 10.3109/14756366.2012.753882
|View full text |Cite
|
Sign up to set email alerts
|

Quantum chemical modeling of the inhibition mechanism of monoamine oxidase by oxazolidinone and analogous heterocyclic compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 42 publications
0
8
0
Order By: Relevance
“…MAO inhibitors also have been studied both experimentally , and theoretically because of their potential use as pharmaceutical products.…”
Section: Introductionmentioning
confidence: 99%
“…MAO inhibitors also have been studied both experimentally , and theoretically because of their potential use as pharmaceutical products.…”
Section: Introductionmentioning
confidence: 99%
“…(3 R ,5 S )-5-(Aminomethyl)-3-(4-methoxyphenyl)dihydrofuran-2(3 H )-one ((3 R ,5 S )- 168 ) was discovered as a potential medication in Parkinson’s disease [99]. Synthesis of enantiomerically pure (3 R ,5 S )- 168 could be accomplished from the aziridine aldehyde (2 S ,1' R )- 6 because the butyrolactone ring formation would proceed with inversion of configuration at C2 in the aziridine ring (Scheme 43) [100].…”
Section: Reviewmentioning
confidence: 99%
“…4 for the 5-(aminomethyl)-3-(4-methoxyphenyl)-2-oxazolidinone which is a well-known time-dependent inactivator of MAO-B. 6,53,54 The PC inv and N5 yl analogs of 5-(aminomethyl)-3-(4-methoxyphenyl)-2-oxazolidinone were optimized (Fig. S1 †) with the same methodology (M06-2X/6-31+G(d,p):PM6) as for serotonin.…”
Section: Mechanism-based Rational Design Of Covalent Reversible Inhib...mentioning
confidence: 99%